Camden National Corp. (Maine)

  • Market Cap: Micro Cap
  • Industry: Regional Banks
  • ISIN: US1330341082
USD
42.64
1.57 (3.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Camden National Corp. (Maine) stock-summary
stock-summary
Camden National Corp. (Maine)
Regional Banks
Camden National Corporation is a bank holding company. The Company is a diversified financial services provider. The primary business of the Company and its subsidiary, Camden National Bank (the Bank), is to attract deposits from, and to extend loans to, consumer, institutional, municipal, non-profit and commercial customers. The Company, through the Bank, offers commercial and consumer banking products and services, and through Camden Financial Consultants and Camden National Wealth Management, divisions of the Bank, brokerage and insurance services, as well as investment management and fiduciary services. The Bank is a national banking association. The Company had 61 banking centers, 84 automated teller machines and three lending offices as of December 31, 2016. The Company operates and manages the Bank's business within Maine's various regions, including Mid Coast, Southern, Central, Bangor and Downeast. Healthcare Professional Funding Corporation is a subsidiary of the Bank.
Company Coordinates stock-summary
Company Details
2 Elm St,, PO Box 310 CAMDEN ME : 04843-1947
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 44 Schemes (38.5%)

Foreign Institutions

Held by 66 Foreign Institutions (5.28%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lawrence Sterrs
Independent Chairman of the Board
Mr. Gregory Dufour
President, Chief Executive Officer, Director
Ms. Ann Bresnahan
Independent Director
Mr. Craig Denekas
Independent Director
Mr. David Flanagan
Independent Director
Ms. S. Catherine Longley
Independent Director
Ms. Marie McCarthy
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
79 Million
(Quarterly Results - Jun 2025)
Net Profit:
14 Million
stock-summary
Industry

Regional Banks

stock-summary
Market cap

USD 686 Million (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

9.01%

stock-summary
Price to Book

1.05